Insight Molecular Diagnostics (IMDX) Return on Capital Employed [ROCE] (2016 - 2026)
Insight Molecular Diagnostics' Return on Capital Employed [ROCE] came in at -204.06% for Q2 2026, down 73.32 percentage points from -130.74% a year earlier but up 27.08 percentage points from the prior quarter.
Powered by 
Analysis
Insight Molecular Diagnostics (IMDX) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends
For FY2025, Insight Molecular Diagnostics' Return on Capital Employed [ROCE] was -278.70%, down 150.77 percentage points from FY2024.
- Return on Capital Employed [ROCE] has declined in each of the last three years, with a five-year change of -201.82 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -127.94% in FY2024 (-96.63 pp), -31.30% in FY2023 (-16.02 pp), -15.29% in FY2022 (+42.25 pp) and -57.54% in FY2021 (+19.35 pp).
- The five-year range for quarterly Return on Capital Employed [ROCE] is -231.13% (Q1 2026) to -11.13% (Q1 2023).
- Year-over-year, Return on Capital Employed [ROCE] has declined for 11 consecutive quarters, with an average year-over-year change of -79.29 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2023 (a gain of 36.27 percentage points), and the weakest in Q4 2024 (a drop of 99.15 percentage points).
- Business Quant data shows IMDX's Return on Capital Employed [ROCE] at -231.13% (Q1 2026), -224.51% (Q4 2025) and -154.97% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 8.30% |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 7.98% |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 6.42% |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 18.58% |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 8.34% |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 13.69% |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 10.83% |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 11.99% |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 6.00% |
| 10 | Insight Molecular Diagnostics | 112.22 Mn | 35.94 Mn | 157,000.00 | -204.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -204.06% |
| Mar 31, 2026 | -231.13% |
| Dec 31, 2025 | -224.51% |
| Sep 30, 2025 | -154.97% |
| Jun 30, 2025 | -130.74% |
| Mar 31, 2025 | -153.99% |
| Dec 31, 2024 | -134.53% |
| Sep 30, 2024 | -68.78% |
| Jun 30, 2024 | -55.74% |
| Mar 31, 2024 | -62.31% |
| Dec 31, 2023 | -35.38% |
| Sep 30, 2023 | -26.92% |
| Jun 30, 2023 | -20.38% |
| Mar 31, 2023 | -11.13% |
| Dec 31, 2022 | -15.43% |
| Sep 30, 2022 | -27.79% |
| Jun 30, 2022 | -37.32% |
| Mar 31, 2022 | -47.40% |
| Dec 31, 2021 | -49.53% |
| Sep 30, 2021 | -28.09% |
API Access
Insight Molecular Diagnostics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();